Alverno Provena Hospital Laboratories
Alverno Provena Hospital Laboratories reported $133.9 million in revenue and $133.8 million in expenses for calendar year 2025. Of every $100 it spent, $90.21 went to program services, $9.79 to management and general costs and $0.00 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 99.7% of the total. The highest compensation it reported for one person was $743,176 (CEO/PRESIDENT (TERM AUG25)). Revenue fell 10% between 2019 and 2025. Source: Form 990, 2025.
Where $100 of spending went
Calendar year 2025 · Form 990, Part IX, line 25 · total expenses $134MFor context, the median across 5,634 covered health care charities: $86.19 programs, $13.81 management, $0.00 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2025 · Form 990, Part VIII · total revenue $134MThe 990 scorecard · same measures for every charity, no grades
| Measure | 2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 90.2% | 85.6% |
| Management & general Part IX 25(C) ÷ 25(A) | 9.8% | 13.7% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.0% | 0.0% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | Not reported | $0.00 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 0.0% | 1.3% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.0% | 0.1% |
| Program service revenue share Part VIII 2g ÷ 12 | 99.7% | 93.7% |
| Highest reported compensation Part VII-A, columns D–F | $743,176 | $975,831 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 0.56% | 1.34% |
| People paid over $100,000 Part VII, line 2 | 0 | 27 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 0.0 | 6.6 |
| Independent voting board members Part VI 1a–1b | 8 of 8 | 88.9% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2025 · Form 990, Part III · the three largest programs by expenseAlverno Provena Hospital Laboratories, inc.'s (aphl) primary function is to provide laboratory testing services to its fourteen (14) affiliated not-for-profit hospitals and affiliates located throughout illinois and indiana. The organization maintains a strategic plan that is structured on the following five areas: stewardship, people, service, growth, and quality. (continued in schedule o)
Highest reported compensation
2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| CEO/PRESIDENT (TERM AUG25) Officer, 32.00 hrs/week | $0 | $714,127 | $29,049 | $743,176 |
| INTERIM CO-CEO Officer, 32.00 hrs/week | $0 | $475,571 | $33,897 | $509,468 |
| INTERIM CO-CEO Officer, 32.00 hrs/week | $0 | $385,800 | $37,230 | $423,030 |
| VP HOSPITAL OPERATIONS Highest compensated employee, 40.00 hrs/week | $0 | $233,457 | $28,253 | $261,710 |
| VP HUMAN RESOURCES Officer, 32.00 hrs/week | $0 | $212,703 | $16,030 | $228,733 |
| ASSOCIATE REGIONAL LAB DIRECTOR Highest compensated employee, 40.00 hrs/week | $0 | $163,137 | $50,126 | $213,263 |
| LAB DIRECTOR III Highest compensated employee, 40.00 hrs/week | $0 | $143,483 | $28,744 | $172,227 |
| LAB DIRECTOR III Highest compensated employee, 40.00 hrs/week | $0 | $145,534 | $19,218 | $164,752 |
0 people received more than $100,000 in reportable compensation from Alverno Provena Hospital Laboratories (Part VII, line 2).
7 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b8 · 8 independent
- Audited financial statements Part XII 2bNo
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aNo
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bNo
- Employees Part I, line 50
- Volunteers Part I, line 68
Correct a figure or respond
Every number above is copied from Alverno Provena Hospital Laboratories's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Alverno Provena Hospital Laboratories, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Alverno Provena Hospital Laboratories spent in 2025, $90.21 went to programs. The full breakdown, from its IRS Form 990:
Questions people ask
How much of Alverno Provena Hospital Laboratories's spending goes to programs?
In calendar year 2025, Alverno Provena Hospital Laboratories reported that 90.2% of its $133.8 million in expenses went to program services, 9.8% to management and general and 0.0% to fundraising (Form 990, Part IX).
How much does Alverno Provena Hospital Laboratories pay its top executive?
The largest total compensation Alverno Provena Hospital Laboratories reported for one person in calendar year 2025 was $743,176, for the role of CEO/PRESIDENT (TERM AUG25) (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Alverno Provena Hospital Laboratories get its money?
Of $133.9 million in revenue in calendar year 2025, 0.0% came from contributions and grants and 99.7% from program service revenue (Form 990, Part VIII).
Is Alverno Provena Hospital Laboratories a registered charity?
The IRS lists EIN 20-3238867 as a 501(c)(3) organization (hospital or medical research organization), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024, 2025. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2025: Form 990 for calendar year 2025, object 202602119349301575 · read the filing
- 2024: Form 990 for calendar year 2024, object 202502959349302160 · read the filing
- 2023: Form 990 for calendar year 2023, object 202413189349302941 · read the filing
- 2022: Form 990 for calendar year 2022, object 202343059349301749 · read the filing
- 2021: Form 990 for calendar year 2021, object 202233139349304343 · read the filing
- 2020: Form 990 for calendar year 2020, object 202133139349303173 · read the filing
- 2019: Form 990 for calendar year 2019, object 202033169349305813 · read the filing
All filings for EIN 20-3238867: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.